优化心脏再同步治疗的实施:呼吁转诊与优化管理:欧洲心脏病学会心力衰竭协会、欧洲心律协会和欧洲心血管影像协会的联合立场声明
该联合立场声明由欧洲心脏病学会的三个协会(心力衰竭协会、欧洲心律协会、欧洲心血管影像协会)发布,聚焦心脏再同步治疗(CRT)的优化实施。声明指出尽管CRT可改善生活质量、降低心衰住院率和全因死亡率,但高达三分之二的符合条件患者未被转诊,且植入后随访常不连贯且不理想。声明围绕四个可操作领域提出理论和实践策略:克服CRT使用不足、更好理解植入前特征、弃用「无反应」一词并以疾病修饰概念替代、实施专门的植入后CRT管理路径。
要点
- 高达三分之二的符合条件患者未被转诊接受CRT,转诊不足是主要问题。
- 声明建议弃用「无反应」一词,以疾病修饰概念替代。
- 声明倡导实施专门的植入后CRT管理路径以优化疗效。
核心结论
- 声明呼吁采取行动优化CRT的转诊和管理,围绕四个可操作领域提出策略。
- CRT是射血分数降低的心力衰竭最有效的疗法之一,可改善生活质量、降低心衰住院率和全因死亡率。
研究设计与样本
- 欧洲心脏病学会心力衰竭协会、欧洲心律协会和欧洲心血管影像协会的联合立场声明。
临床应用与阅片要点
- 声明聚焦于克服CRT使用不足、更好理解植入前特征、弃用「无反应」并以疾病修饰替代、实施专门的植入后CRT管理路径四个领域。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart failure with reduced ejection fraction and leads to improved quality of life, reductions in heart failure hospitalization rates and all-cause mortality. Nevertheless, up to two-thirds of eligible patients are not referred for CRT. Furthermore, post-implantation follow-up is often fragmented and suboptimal, hampering the potential maximal treatment effect. This joint position statement from three European Society of Cardiology Associations, Heart Failure Association (HFA), European Heart Rhythm Association (EHRA) and European Association of Cardiovascular Imaging (EACVI), focuses on optimized implementation of CRT. We offer theoretical and practical strategies to achieve more comprehensive CRT referral and post-procedural care by focusing on four actionable domains: (i) overcoming CRT under-utilization, (ii) better understanding of pre-implant characteristics, (iii) abandoning the term 'non-response' and replacing this by the concept of disease modification, and (iv) implementing a dedicated post-implant CRT care pathway.
引用
- Mullens W, Auricchio A, Martens P, et al. Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology. Eur J Heart Fail. 2020. PMID: 33136300. doi:10.1002/ejhf.2046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。